Bioprocessing Systems Market

Bioprocessing systems sales will expand through 2036, with single-use systems at 44.3% within the process segment, vaccine development at 32.0% of the application category and biopharmaceutical companies at 48.0% of end-user demand in 2026. The market is projected to record a 14.3% CAGR between 2026 and 2036.